Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hauser

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 30, 2010
A novel P300-based brain-computer interface stimulus presentation paradigm: moving beyond rows and columnsG Townsend, B K LaPallo, C B Boulay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Nature Communications|August 16, 2018
Two-dimensional type-II Dirac fermions in layered oxidesM Horio, C E Matt, K Kramer, et al.
Neurobiology of Disease|July 3, 2007
Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalitiesK Grundmann, B Reischmann, G Vanhoutte, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
European Journal of Neurology|March 16, 2013
No association of GBA mutations and multiple system atrophyK Srulijes, A-K Hauser, I Guella, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluationGraeme Semple, Thuy-Anh Tran, Bryan Kramer, et al.
Journal of Medicinal Chemistry|August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Journal of Medicinal Chemistry|August 6, 2010
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomniaYifeng Xiong, Brett Ullman, Jin-Sun Karoline Choi, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 30, 2010
A novel P300-based brain-computer interface stimulus presentation paradigm: moving beyond rows and columnsG Townsend, B K LaPallo, C B Boulay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Nature Communications|August 16, 2018
Two-dimensional type-II Dirac fermions in layered oxidesM Horio, C E Matt, K Kramer, et al.
Neurobiology of Disease|July 3, 2007
Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalitiesK Grundmann, B Reischmann, G Vanhoutte, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
European Journal of Neurology|March 16, 2013
No association of GBA mutations and multiple system atrophyK Srulijes, A-K Hauser, I Guella, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluationGraeme Semple, Thuy-Anh Tran, Bryan Kramer, et al.
Journal of Medicinal Chemistry|August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Journal of Medicinal Chemistry|August 6, 2010
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomniaYifeng Xiong, Brett Ullman, Jin-Sun Karoline Choi, et al.
Pageof 9